Clinical Outcomes of Endoscopic Resection for Treating WHYX Lesion
Phase 4
Completed
- Conditions
- WHYX LesionExtremely Well Differentiated Intestinal-type Adenocarcinoma
- Interventions
- Procedure: WHYX cancer group
- Registration Number
- NCT01451034
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Endoscopically, WHYX cancers demonstrated a vague extent of tumor spread due to pale color changes in both the background atrophic and metaplastic gastric mucosa. However, the clinical outcomes of WHYX cancers after endoscopic resection are unknown. The aim of this study was to evaluate clinical outcomes of WHYX cancers after endoscopic resection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 872
Inclusion Criteria
- From January 2009 to December 2010 enrolled 872 patients with EGC
Exclusion Criteria
- EGC with regional lymph node metastasis in radiologic finding endoscopically suspicious submucosal invasion
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description WHYX cancer group WHYX cancer group WHYX cancer diagnosed by pathologic report non-WHYX cancer group WHYX cancer group all cancer except WHYX cancer diagnosed by pathologic report
- Primary Outcome Measures
Name Time Method complete resection rate 6 months after endoscopical resection Complete resection was defined to have all of the following features: 1. grossly en bloc resection, 2. Tumor-free lateral and vertical resection margins, 3. No lymphovascular invasion, and 5. A depth of submucosal tumor invasion of less than 500 micrometers.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of